Ibuprofen Recalled Over Labeling Error

According to Medscape, American Health Packaging (AHP) has initiated a voluntary nationwide recall of one lot of ibuprofen tablets and one lot of oxcarbazepine tablets because of mislabeling.

The recall was announced through a press release on the US Food and Drug Administration web site. The products were reportedly distributed nationwide beginning June 20, 2014 and intended for hospital usage.

The recall included the ibuprofen tablets in Lot #142588, which according to Medscape, may contain individual blistered doses mistakenly labeled as oxcarbazepine tablets. The packages involved in the recall contain the National Drug Code (NDC) 68084-703-01 and individual dose NDC 68084-703-11.

“Failure to receive the proper dose of oxcarbazepine could increase the chances of having a seizure. Inadvertent consumption of ibuprofen may cause adverse reactions in a number of patients in which use of ibuprofen is contraindicated,” the press release said.

Oxcarbazepine is used to treat epilepsy and is a mood-stabilizing drug. The FDA press release can be viewed by clicking here.

What Can I Do If a Recalled Drug Injures Me?

Recalls over label issues are especially troubling. Our attorneys are dedicated to making sure companies produce safer products. We rely upon over 70 years of combined experience in pharmaceutical mass torts and multidistrict litigation to accomplish this goal.

If you or a loved one is ever injured by a defective drug, contact us so that we may investigate your case. We have considerable experience in pharmaceutical, medical device and defective product litigation, including filing product liability lawsuits on behalf of victims.

Zoll & Kranz, LLC – Defective Medical Drug and Device Lawyers